EU nod for Sandoz’ Remicade biosimilar Zessly by Selina McKee | May 24, 2018 | News | 0 The European Commission has green-lighted Novartis unit Sandoz’ Zessly, a biosimilar version of Johnson & Johnson and Merck & Co’s Remicade Read More
Six new therapies backed for EU approval by Selina McKee | Mar 28, 2018 | News | 0 Six medicines have taken a big step towards European approval having been recommended by the European Medicines Agency’s Committee for Medicinal Products for Human Use. Read More